RyanPatrickWerntzMD

PubMed

• Bilateral Nerve-Sparing Robot-Assisted Retroperitoneal Lymph Node Dissection: A Minimally Invasive Approach.
  Carter J Colwell, Johnny R Lindquist, Ryan P Werntz> ;Journal of Endourology. 2022 Sep 1
• Editorial Comment.
  Ryan Werntz> ;The Journal of Urology. 2021 Mar 1
• 8 citations
  The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle in...
  Vignesh T. Packiam, Craig Labbate, Stephen A. Boorjian, Robert F. Tarrell, John C. Cheville, Svetlana Avulova, Vidit Sharma, Matvey Tsivian, Brittany Adamic, Mohammad ...> ;Urologic Oncology. 2021 Jul 1
• A rare case of pancreatic adenocarcinoma metastasized to the bladder.
  James Frederick W. Pike, William F. Abel, Jordan M. Eldersveld, Charles G. Marguet, Ryan P. Werntz> ;Urology Case Reports. 2020 Nov 1
• 2 citations
  National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy.
  Craig Labbate, Ryan P. Werntz, Logan Galansky, Vignesh T. Packiam, Scott E. Eggener> ;Urologic Oncology. 2020 Aug 1
• Transurethral resection and surveillance of a well-differentiated neuroendocrine tumor in a ileal neobladder
  Audry Kang, Brittany Adamic, Caleb A. Cooper, Gladell P. Paner, Ryan P. Werntz> ;Urology Case Reports. 2020 May 14
• 14 citations
  The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy
  Ryan P. Werntz, Zachary L. Smith, Vignesh T. Packiam, Norm D. Smith, Gary D. Steinberg> ;European Urology Focus. 2020 Mar 15
• 2 citations
  Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors
  Ryan P. Werntz, Scott E. Eggener> ;Translational Andrology and Urology. 2020 Jan 1
• 63 citations
  Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
  Craig Labbate, Ken Hatogai, Ryan P. Werntz, Walter M. Stadler, Gary D. Steinberg, Scott E. Eggener, Randy F. Sweis> ;Journal for Immunotherapy of Cancer. 2019 Dec 1
• 29 citations
  Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage
  Vignesh T. Packiam, Ryan P. Werntz, Gary D. Steinberg> ;Current Urology Reports. 2019 Nov 28
• 8 citations
  Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.
  Andrea B. Apolo, Matthew I. Milowsky, Lauren Kim, Brant A. Inman, Ashish M. Kamat, Gary D. Steinberg, Mohammadhadi Bagheri, Venkatesh Krishnasamy, Jamie Marko, Colin P...> ;JAMA Oncology. 2019 Dec 1
• Reply by Authors.
  Craig Labbate, Ryan P Werntz, Brittany Adamic, Gary D Steinberg> ;The Journal of Urology. 2019 Oct 1
• 10 citations
  Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC).
  Ryan P. Werntz, Brittany Adamic, Gary D. Steinberg> ;World Journal of Urology. 2019 Oct 1
• 1 citations
  Re: Use of Active Surveillance or Watchful Waiting for Low-risk Prostate Cancer and Management Trends Across Risk Groups in the United States 2010-2015.
  Ryan P. Werntz, Scott E. Eggener> ;European Urology. 2019 Aug 1
• 9 citations
  The Impact of Omission of Intraoperative Frozen Section Prior to Orthotopic Neobladder Reconstruction
  Craig Labbate, Ryan P. Werntz, Brittany Adamic, Gary D. Steinberg> ;The Journal of Urology. 2019 Sep 6
• 14 citations
  The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data.
  Christopher B. Riedinger, Richard J. Fantus, Richard S. Matulewicz, Ryan P. Werntz, Joseph F. Rodriguez, Norm D. Smith> ;Prostate Cancer and Prostatic Diseases. 2019 May 1
• 8 citations
  The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
  Ryan P. Werntz, Christopher B. Riedinger, Richard J. Fantus, Zachary L. Smith, Vignesh T. Packiam, Melanie Adamsky, Norm D. Smith, Gary D. Steinberg> ;Urologic Oncology. 2018 Nov 13
• Editorial Comment.
  Ryan P Werntz, Gary D Steinberg> ;The Journal of Urology. 2018 Nov 1
• 4 citations
  Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
  Ryan P. Werntz, Shane M. Pearce, Scott E. Eggener> ;Current Opinion in Urology. 2018 Sep 1
• Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later
  Christopher B. Riedinger, Craig Labbate, Ryan P. Werntz, Scott E. Eggener> ;Urology. 2018 Aug 28
• 30 citations
  Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions.
  Jeanny B Aragon-Ching, Ryan P. Werntz, Anthony L. Zietman, Gary D. Steinberg> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2018 May 23
• 24 citations
  Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source
  Ryan P. Werntz, Ann Martinez-Acevedo, Hamed Amadi, Ryan Kopp, Jeffrey C. La Rochelle, Theresa M. Koppie, Christopher L. Amling, Kamran P. Sajadi> ;Urologic Oncology. 2018 May 1
• 93 citations
  Testicular Cancer: Epidemiology, Diagnosis, and Management
  Zachary L. Smith, Ryan P. Werntz, Scott E. Eggener> ;The Medical Clinics of North America. 2018 Mar 1
• 1 citations
  A Simple Neobladder Using a Porcine Model: The Double Limb U-Pouch
  Ryan P. Werntz, Poone Shoureshi, Kyle A. Gillis, Akash Kapadia, David Jiang, Christopher L. Amling, John M. Barry> ;Urology. 2017 Dec 1
• 7 citations
  Novel focal therapy treatment options for prostate cancer.
  Ryan P. Werntz, Scott E. Eggener> ;Current Opinion in Urology. 2017 Dec 1
• Join now to see all